Alpha1 Proteinase Inhibitor Deficiency clinical trials

Explore recruiting alpha1 proteinase inhibitor deficiency clinical trials.

Recruiting alpha1 proteinase inhibitor deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alpha1 Proteinase Inhibitor Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 4, Multicenter, Double-blind, Study to Investigate the Efficacy, Safety, and Tolerability of 3 Active Doses of Respreeza® / Zemaira® Weekly Intravenous Infusions Administered over 3 Years as Longterm Maintenance Therapy in Adult Subjects with Emphysema Related to Alpha1 Antitrypsin Deficiency

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Alpha1 Proteinase Inhibitor Deficiency trials by city

Alpha1 Proteinase Inhibitor Deficiency in Toronto Alpha1 Proteinase Inhibitor Deficiency in Vancouver Alpha1 Proteinase Inhibitor Deficiency in Montreal Alpha1 Proteinase Inhibitor Deficiency in Calgary Alpha1 Proteinase Inhibitor Deficiency in Edmonton Alpha1 Proteinase Inhibitor Deficiency in Ottawa Alpha1 Proteinase Inhibitor Deficiency in Winnipeg Alpha1 Proteinase Inhibitor Deficiency in Quebec City Alpha1 Proteinase Inhibitor Deficiency in Hamilton Alpha1 Proteinase Inhibitor Deficiency in Kitchener Alpha1 Proteinase Inhibitor Deficiency in London Alpha1 Proteinase Inhibitor Deficiency in Halifax Alpha1 Proteinase Inhibitor Deficiency in New York Alpha1 Proteinase Inhibitor Deficiency in Los Angeles Alpha1 Proteinase Inhibitor Deficiency in Chicago Alpha1 Proteinase Inhibitor Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease